🇵🇱 Poland Country × Condition
prostate cancer Clinical Trials in Poland
Active clinical trials for prostate cancer with research sites in Poland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇵🇱 Poland
Active Trials in Poland (2)
NCT07426094 Phase 2, Phase 3
Recruiting
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
Enrollment
600 pts
Country
🇵🇱 Poland
Affidea Nu-med Center of Oncologica...
View Trial → NCT05582876
Recruiting
Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer
Enrollment
366 pts
Country
🇵🇱 Poland
Medical University of Bialystok
View Trial → Frequently Asked Questions
How many prostate cancer clinical trials are active in Poland?
There are currently 2 active clinical trials for prostate cancer with sites in Poland, of which 2 are actively recruiting patients.
How can I join a prostate cancer clinical trial in Poland?
To join a prostate cancer clinical trial in Poland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Poland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in Poland?
Active prostate cancer trials in Poland span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology